In addition to downregulating MYB in CRC, miR-150 also directly lowers the expression of ß-catenin [278], VEGFA [279], and a known marker of poor prognoses in CRC patients, MUC4 [280]. This evidence concerns the gene VEGFA and colorectal carcinoma.